Literature DB >> 17253137

Expandable polyester silicon-covered stent for malignant esophageal strictures before neoadjuvant chemoradiation: a pilot study.

Ali A Siddiqui1, David Loren, Robert Dudnick, Thomas Kowalski.   

Abstract

Patients with resectable esophageal cancer often require placement of a surgical jejunostomy tube prior to receiving chemoradiation so as to maintain adequate nutrition due to their inability to swallow and eat. This study reports a single institutional experience with the Polyflex self-expanding silicone stent (Riisch; Kernen. Germany) in patients with malignant stenosis receiving chemoradiation prior to esophagectomy. This was a retrospective, nonrandomized study of 6 patients who underwent Polyflex esophageal stent placement across a malignant stricture prior to receiving neoadjuvant chemoradiation. The study assessed procedural success, restoration of oral nutrition, migration, and removal of the Polyflex stent. The outcomes measured were the efficacy of treatment, stent-related complications, and changes in the nutritional status of the patient after stent placement. Stent placement was successful in 5 of 6 patients (83%). Restoration of oral nutrition after stent placement occurred in 5 of 5 patients (100%). Migration of the stent into the stomach occurred in 3 patients (60%) without occurrence of gastric outlet obstruction; there was no proximal migration. Stents were successfully removed endoscopically or at the time of esophagectomy. This early experience suggests that the removable silicone Polyflex stent is an effective alternative to a surgical jejunostomy tube for the management of malignant esophageal stenosis in patients for whom neoadjuvant chemoradiation is planned prior to esophagectomy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17253137     DOI: 10.1007/s10620-006-9513-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  27 in total

1.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

Authors:  A Herskovic; K Martz; M al-Sarraf; L Leichman; J Brindle; V Vaitkevicius; J Cooper; R Byhardt; L Davis; B Emami
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

2.  A prospective trial of a new self-expanding plastic stent for malignant esophageal obstruction.

Authors:  N Bethge; N Vakil
Journal:  Am J Gastroenterol       Date:  2001-05       Impact factor: 10.864

3.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

4.  Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia.

Authors:  R H Park; M C Allison; J Lang; E Spence; A J Morris; B J Danesh; R I Russell; P R Mills
Journal:  BMJ       Date:  1992-05-30

5.  Laparoscopic gastrostomy and jejunostomy: safety and cost with local vs general anesthesia.

Authors:  Q Y Duh; A L Senokozlieff-Englehart; Y S Choe; A E Siperstein; K Rowland; L W Way
Journal:  Arch Surg       Date:  1999-02

6.  Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures.

Authors:  G Costamagna; S K Shah; A Tringali; M Mutignani; V Perri; M E Riccioni
Journal:  Surg Endosc       Date:  2003-03-07       Impact factor: 4.584

7.  [New indications in the treatment of advanced esophageal cancer using self-expanding stent].

Authors:  István Kovács; Katalin Dévényi; Sándor Kiss
Journal:  Magy Seb       Date:  2002-08

8.  Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival.

Authors:  T N Walsh; M Grennell; S Mansoor; A Kelly
Journal:  Dis Esophagus       Date:  2002       Impact factor: 3.429

9.  Usefulness of self-expandable metallic stent with an antireflux mechanism as a palliation for malignant strictures at the gastroesophageal junction.

Authors:  H Osugi; S Lee; M Higashino; T Tokuhara; S Kaseno; N Takada; M Takemura; Y Mizumoto; H Kinoshita
Journal:  Surg Endosc       Date:  2002-06-20       Impact factor: 4.584

Review 10.  Multiple management modalities in esophageal cancer: combined modality management approaches.

Authors:  Mary Koshy; Natia Esiashvilli; Jerome C Landry; Charles R Thomas; Richard H Matthews
Journal:  Oncologist       Date:  2004
View more
  7 in total

1.  First reported case of intentional use of a duodenal stent to treat gastric outlet obstruction prior to pancreaticoduodenectomy in a patient with pancreatic cancer.

Authors:  Sarah Ahmad; Douglas G Adler
Journal:  Dig Dis Sci       Date:  2013-10-11       Impact factor: 3.199

2.  The use of biodegradable (SX-ELLA) oesophageal stents to treat dysphagia due to benign and malignant oesophageal disease.

Authors:  Ewen A Griffiths; Catherine J Gregory; Kishore G Pursnani; Jeremy B Ward; Robert C Stockwell
Journal:  Surg Endosc       Date:  2012-03-07       Impact factor: 4.584

3.  Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.

Authors:  Zachary L Smith; Jason E Gonzaga; George B Haasler; Elizabeth M Gore; Kulwinder S Dua
Journal:  Dig Dis Sci       Date:  2017-04-08       Impact factor: 3.199

Review 4.  Designing Expandable-Structure Robots for Human-Robot Interaction.

Authors:  Hooman Hedayati; Ryo Suzuki; Wyatt Rees; Daniel Leithinger; Daniel Szafir
Journal:  Front Robot AI       Date:  2022-04-11

5.  Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis.

Authors:  Vinayak Nagaraja; Michael R Cox; Guy D Eslick
Journal:  J Gastrointest Oncol       Date:  2014-04

6.  Dilation of benign strictures in the esophagus and colon with the polyflex stent: a case series study.

Authors:  Jesús García-Cano
Journal:  Dig Dis Sci       Date:  2007-06-13       Impact factor: 3.199

7.  Endoscopic stenting: where are we now and where can we go?

Authors:  Mark-Terence McLoughlin; Michael-Francis Byrne
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.